Track Align Technology, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Align Technology, Inc. ALGN · Stock Open Align Technology, Inc. in new tab

168.32 USD
P/E
24.54
EPS
6.86
P/B
2.76
ROE
11.91
Beta
1.74
Target Price
185.79 USD
Align Technology, Inc. logo

Align Technology, Inc.

🧾 Earnings Recap – Q3 2026

Align reported Q3 revenue of $1.015 billion, up 1.9% year over year, with Clear Aligner shipments up 6.6%; the stock was essentially flat at +0.1%. Gross margin came in modestly below the company’s expectation, while operating margin was above its outlook.

  • Clear Aligner shipments rose 6.6% to 691,000, at the high end of the company’s expected mid-single-digit growth; record doctor submitters reached 91,000, up more than 3%.
  • Systems and Services revenue fell 7.6% to $175.5 million, reflecting a shift toward lower-priced scanner configurations and more flexible acquisition models.
  • Non-GAAP gross margin was 70.4%, modestly below expectation due to higher fuel-related transportation costs, lower Clear Aligner ASP and geographic and product mix. Non-GAAP operating margin was 24.4%, above outlook.
  • Americas Clear Aligner shipments increased approximately 1.5%; North American DSO shipments grew at a double-digit rate, while the broader retail channel remained pressured, particularly among GP customers.
  • Worldwide Zero Additional Aligner volume increased at a triple-digit rate year over year; international younger-patient shipments grew at a double-digit rate.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 3, 2027
P/E24.54
EPS6.86
Book Value60.91
Price to Book2.76
Debt/Equity3.40
% Insiders8.746%
Growth
Revenue Growth0.02%
Earnings Growth1.44%
Estimates
Forward P/E13.70
Forward EPS12.29
Target Mean Price185.79

DCF valuation

Model fair value for Align Technology, Inc. (ALGN)
Result
Sign in to run the valuation for ALGN.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
14 analysts · consensus Buy · mean target 185.79 USD (low 160.00, high 210.00) · as of 14 Nov 2026
Low 160.00
Mean 185.79
High 210.00
Price 168.32
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Align Technology, Inc. Logo Align Technology, Inc. Analysis (ALGN)

United States Health Care Official Website Stock

Is Align Technology, Inc. a good investment? Align Technology, Inc. (ALGN) is currently trading at 168.32 USD. Market analysts have a consensus price target of 185.79 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 24.54. This valuation is generally in line with the broader market.

Earnings Schedule: Align Technology, Inc. is expected to release its next earnings report on Feb. 3, 2027. The market consensus estimate for Forward EPS is 12.29.

Investor FAQ

Does Align Technology, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Align Technology, Inc.?

Align Technology, Inc. is classified as a Stock. You can compare it against 3 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 3, 2027. The company currently has a trailing EPS of 6.86.

Company Profile

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Exchange Ticker
NMS (United States) ALGN
FRA (Germany) AFW.F
US0162551016
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion